RVTY
Revvity, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Strong buy
+67/100
Last price
153.30
▼ 4.06 (2.58%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
157.36
Day high
166.25
Day low
151.45
Volume
2.68M
Market cap
$17.11B
P/E (TTM)
73.35
52W range
81.22 – 166.25
Trailing performance
Returnvs SPY
1W
+0.35%
-1.6%
1M
+17.72%
+16.6%
3M
+40.19%
+35.7%
6M
+74.62%
+56.4%
YTD
+58.45%
+44.2%
1Y
+63.00%
+46.6%
3Y
+38.48%
-43.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on RVTY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+114.48K
Net buying
Buy transactions
12
116.28K shares
Sell transactions
3
1.80K shares
Net transactions
+15
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
291.24K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 21, 26 | KRAKOWIAK MAXWELL Chief Financial Officer |
SELL | 1.63K | $235.73K | Direct |
| Aug 25, 26 | MICHAS ALEXANDROS P Director |
STOCK | 285 | $0 | Indirect |
| Aug 14, 26 | GOLDBERG JOEL S General Counsel |
STOCK | 27.79K | $0 | Direct |
| Aug 13, 26 | SINGH PRAHLAD R Chief Executive Officer |
STOCK | 67.29K | $0 | Direct |
| Jul 20, 26 | GONZALES ANITA Officer |
SELL | 85 | $9.31K | Direct |
| May 7, 26 | WITNEY FRANKLIN R. PH.D. Director |
STOCK | 2.28K | $0 | Direct |
| May 7, 26 | BARRETT PETER Director |
STOCK | 2.28K | $0 | Direct |
| May 7, 26 | MICHAS ALEXANDROS P Director |
STOCK | 2.68K | $0 | Direct |
| May 7, 26 | VOUNATSOS MICHEL PERICLES Director |
STOCK | 2.28K | $0 | Direct |
| May 7, 26 | CHAPIN SAMUEL R. Director |
STOCK | 2.28K | $0 | Direct |
| May 7, 26 | VANDEBROEK SOPHIE V Director |
STOCK | 2.28K | $0 | Direct |
| May 7, 26 | WITZ PASCALE Director |
STOCK | 2.28K | $0 | Direct |
| May 7, 26 | KLOBUCHAR MICHAEL A Director |
STOCK | 2.28K | $0 | Direct |
| May 7, 26 | MCMURRY-HEATH MICHELLE Director |
STOCK | 2.28K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARRETT PETER |
Director | 28.29K | Stock Award(Grant) |
CHAPIN SAMUEL R. |
Director | 22.68K | Stock Award(Grant) |
GOLDBERG JOEL S |
General Counsel | 105.22K | Stock Gift |
KRAKOWIAK MAXWELL |
Chief Financial Officer | 14.78K | Sale |
MICHAS ALEXANDROS P |
Director | — | Stock Gift |
MICHAS ALEXIS P |
Director | — | Sale |
SINGH PRAHLAD R |
Chief Executive Officer | 105.68K | Stock Gift |
VICTOR MIRIAME |
Officer | 18.12K | Sale |
WITNEY FRANKLIN R. PH.D. |
Director | 23.35K | Stock Award(Grant) |
WITZ PASCALE |
Director | 15.98K | Stock Award(Grant) |
Fundamentals
Market cap$17.11B
Enterprise value$19.42B
Revenue (TTM)$2.91B
Gross profit$1.60B
EBITDA$875.83M
Net income$237.37M
EPS (TTM)$2.09
Free cash flow$604.99M
Total cash$1.02B
Total debt$3.34B
Book value / share$64.78
Shares outstanding111.59M
Float102.49M
Short % of float8.35%
Dividend yield0.18%
Beta (5Y)1.06
Valuation & profitability ratios
Trailing P/E73.35
Forward P/E26.02
PEG ratio0.73
Price / sales—
Price / book2.37
EV / revenue6.67
EV / EBITDA22.18
Gross margin54.98%
Operating margin17.05%
Profit margin8.16%
Return on equity3.21%
Return on assets2.37%
Debt / equity46.23
Current ratio1.80
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.86B | $2.76B | $2.75B | $3.31B | +3.7% |
| Operating revenue | $2.86B | $2.76B | $2.75B | $3.31B | +3.7% |
| Cost of revenue | $1.29B | $1.22B | $1.21B | $1.32B | +6.1% |
| Gross profit | $1.56B | $1.54B | $1.54B | $1.99B | +1.7% |
| Research & development | $215.84M | $196.84M | $216.58M | $221.62M | +9.7% |
| Selling, general & admin | $991.89M | $994.07M | $1.02B | $1.03B | -0.2% |
| Total operating expense | $1.21B | $1.19B | $1.24B | $1.25B | +1.4% |
| Operating income | $356.63M | $346.74M | $300.56M | $742.70M | +2.9% |
| Net interest income | -$61.08M | -$23.09M | -$26.68M | -$100.37M | -164.6% |
| Pre-tax income | $268.28M | $316.13M | $182.98M | $651.84M | -15.1% |
| Tax provision | $28.39M | $33.05M | $3.47M | $139.16M | -14.1% |
| Net income | $241.20M | $270.38M | $693.09M | $569.18M | -10.8% |
| Net income to common | $241.20M | $270.38M | $693.09M | $569.18M | -10.8% |
| Basic EPS | 2.15 | 2.24 | 5.62 | 4.59 | -4.1% |
| Diluted EPS | 2.07 | 2.20 | 5.55 | 4.58 | -5.9% |
| EBIT | $360.46M | $412.40M | $281.79M | $755.79M | -12.6% |
| EBITDA | $765.80M | $840.25M | $713.56M | $1.18B | -8.9% |
| Basic shares | 112.28M | 120.65M | 123.43M | 126.30M | -6.9% |
| Diluted shares | 116.59M | 122.82M | 124.81M | 126.43M | -5.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $919.86M | $1.16B | $913.16M | $454.36M | -20.9% |
| Cash & short-term investments | $919.86M | $1.16B | $1.60B | $454.36M | -20.9% |
| Accounts receivable | $744.67M | $632.40M | $632.81M | $612.78M | +17.8% |
| Inventory | $379.50M | $367.59M | $428.06M | $405.46M | +3.2% |
| Total current assets | $2.24B | $2.35B | $3.00B | $3.29B | -4.7% |
| Property, plant & equipment | $644.69M | $649.93M | $664.74M | $671.30M | -0.8% |
| Goodwill & intangibles | $8.96B | $9.10B | $9.56B | $9.86B | -1.6% |
| Total assets | $12.17B | $12.39B | $13.56B | $14.13B | -1.8% |
| Total current liabilities | $1.33B | $653.10M | $1.45B | $1.54B | +103.8% |
| Current debt | $588.83M | $242.00K | $721.87M | $470.93M | +243,217.4% |
| Long-term debt | $2.63B | $3.15B | $3.18B | $3.92B | -16.5% |
| Total debt | $3.40B | $3.33B | $4.07B | $4.60B | +2.2% |
| Total liabilities | $4.92B | $4.73B | $5.69B | $6.75B | +4.1% |
| Retained earnings | $6.05B | $5.85B | $5.61B | $4.95B | +3.6% |
| Shareholder equity | $7.25B | $7.67B | $7.87B | $7.38B | -5.4% |
| Working capital | $908.50M | $1.70B | $1.55B | $1.74B | -46.4% |
| Net tangible assets | -$1.71B | -$1.44B | -$1.68B | -$2.48B | -19.0% |
| Shares issued | 112.28M | 120.65M | 123.43M | 126.30M | -6.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $239.88M | $283.07M | $179.50M | $512.68M | -15.3% |
| Depreciation & amortisation | $405.34M | $427.85M | $431.77M | $427.00M | -5.3% |
| Stock-based compensation | $22.85M | $37.81M | $41.41M | $51.52M | -39.6% |
| Change in working capital | -$96.78M | -$18.30M | -$391.35M | -$262.97M | -428.7% |
| Operating cash flow | $582.93M | $628.30M | $91.27M | $679.81M | -7.2% |
| Capital expenditure | -$73.52M | -$86.65M | -$81.37M | -$85.63M | +15.1% |
| Investing cash flow | -$17.35M | $776.16M | $1.31B | -$132.85M | -102.2% |
| Share buybacks | -$820.82M | -$369.58M | -$388.88M | -$80.64M | -122.1% |
| Dividends paid | -$32.80M | -$34.45M | -$34.97M | -$35.34M | +4.8% |
| Financing cash flow | -$857.52M | -$1.13B | -$947.12M | -$661.80M | +24.0% |
| Free cash flow | $509.41M | $541.65M | $9.90M | $594.18M | -6.0% |
| End cash position | $921.03M | $1.16B | $914.37M | $470.75M | -20.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $729.69M | $711.12M | $772.06M | $698.95M | $720.28M | +2.6% |
| Operating revenue | $729.69M | $711.12M | $772.06M | $698.95M | $720.28M | +2.6% |
| Cost of revenue | $312.82M | $323.46M | $350.40M | $324.35M | $327.73M | -3.3% |
| Gross profit | $416.87M | $387.65M | $421.66M | $374.60M | $392.56M | +7.5% |
| Research & development | $48.97M | $57.89M | $58.18M | $50.80M | $53.27M | -15.4% |
| Selling, general & admin | $280.04M | $253.88M | $251.73M | $241.91M | $250.22M | +10.3% |
| Total operating expense | $329.01M | $311.77M | $309.91M | $292.71M | $303.49M | +5.5% |
| Operating income | $87.85M | $75.89M | $111.75M | $81.90M | $89.06M | +15.8% |
| Net interest income | -$17.73M | -$18.41M | -$17.76M | -$15.85M | -$14.59M | +3.7% |
| Pre-tax income | $63.53M | $49.99M | $91.56M | $55.69M | $68.65M | +27.1% |
| Tax provision | $10.05M | $9.10M | -$4.21M | $8.46M | $13.43M | +10.5% |
| Net income | $51.82M | $40.72M | $98.36M | $46.65M | $53.95M | +27.3% |
| Net income to common | $51.82M | $40.72M | $98.36M | $46.65M | $53.95M | +27.3% |
| Basic EPS | 0.46 | 0.36 | 0.88 | 0.41 | 0.46 | +27.5% |
| Diluted EPS | 0.46 | 0.36 | 0.87 | 0.40 | 0.46 | +29.0% |
| EBIT | $58.27M | $74.71M | $115.07M | $78.46M | $60.30M | -22.0% |
| EBITDA | $160.31M | $179.77M | $218.15M | $180.52M | $163.08M | -10.8% |
| Basic shares | 111.58M | 111.63M | 112.28M | 114.03M | 116.33M | -0.0% |
| Diluted shares | 111.63M | 111.88M | 113.21M | 115.46M | 117.54M | -0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.02B | $860.32M | $919.86M | $931.39M | $991.85M | +18.9% |
| Cash & short-term investments | $1.02B | $860.32M | $919.86M | $931.39M | $991.85M | +18.9% |
| Accounts receivable | $709.17M | $691.38M | $744.67M | $680.26M | $661.14M | +2.6% |
| Inventory | $378.50M | $387.50M | $379.50M | $379.92M | $388.47M | -2.3% |
| Total current assets | $2.30B | $2.13B | $2.24B | $2.14B | $2.24B | +8.0% |
| Property, plant & equipment | $607.20M | $628.89M | $644.69M | $668.17M | $676.19M | -3.4% |
| Goodwill & intangibles | $8.83B | $8.92B | $8.96B | $9.03B | $9.13B | -1.0% |
| Total assets | $12.05B | $12.00B | $12.17B | $12.14B | $12.36B | +0.4% |
| Total current liabilities | $1.28B | $1.24B | $1.33B | $1.22B | $671.81M | +3.0% |
| Current debt | $572.16M | $575.83M | $588.83M | $583.84M | $230.00K | -0.6% |
| Long-term debt | $2.63B | $2.63B | $2.63B | $2.63B | $3.21B | +0.0% |
| Total debt | $3.34B | $3.35B | $3.40B | $3.37B | $3.37B | -0.3% |
| Total liabilities | $4.82B | $4.81B | $4.92B | $4.76B | $4.81B | +0.1% |
| Retained earnings | $6.13B | $6.09B | $6.05B | $5.96B | $5.93B | +0.7% |
| Shareholder equity | $7.23B | $7.18B | $7.25B | $7.38B | $7.56B | +0.6% |
| Working capital | $1.02B | $889.67M | $908.50M | $921.04M | $1.56B | +14.8% |
| Net tangible assets | -$1.60B | -$1.73B | -$1.71B | -$1.65B | -$1.57B | +7.6% |
| Shares issued | 111.58M | 111.63M | 112.28M | 114.03M | 116.33M | -0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $53.48M | $40.89M | $95.77M | $47.22M | $55.22M | +30.8% |
| Depreciation & amortisation | $102.04M | $105.06M | $103.08M | $102.06M | $102.78M | -2.9% |
| Stock-based compensation | $10.73M | $8.71M | -$4.07M | $9.05M | $10.13M | +23.1% |
| Change in working capital | -$18.08M | -$39.72M | $1.09M | -$35.71M | -$48.86M | +54.5% |
| Operating cash flow | $191.94M | $115.23M | $181.96M | $138.50M | $134.32M | +66.6% |
| Capital expenditure | -$11.07M | -$19.77M | -$20.17M | -$18.50M | -$18.87M | +44.0% |
| Investing cash flow | -$3.50M | -$78.27M | -$20.45M | $18.97M | -$9.49M | +95.5% |
| Share buybacks | -$15.99M | -$86.50M | -$168.28M | -$205.03M | -$293.91M | +81.5% |
| Dividends paid | -$7.81M | -$7.84M | -$7.96M | -$8.13M | -$8.28M | +0.3% |
| Financing cash flow | -$23.16M | -$88.89M | -$176.31M | -$215.07M | -$302.48M | +73.9% |
| Free cash flow | $180.87M | $95.45M | $161.79M | $120.00M | $115.45M | +89.5% |
| End cash position | $1.02B | $861.47M | $921.03M | $932.58M | $992.99M | +18.9% |
Options analytics
Put / call volume
7.54
Put-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
60.00
-60.9% from spot
ATM implied vol
1.6%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
134
Contracts, this expiry
Put volume
1.01K
Contracts, this expiry
Heaviest call OI
90.00
0 contracts
Heaviest put OI
60.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.22 | 1.41 | +15.9% |
| Mar 2026 | 1.01 | 1.06 | +4.5% |
| Dec 2025 | 1.58 | 1.70 | +7.8% |
| Sep 2025 | 1.14 | 1.18 | +3.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.30 | 15 | $694.73M | -0.6% |
| Next quarter | 1.61 | 15 | $759.71M | -1.6% |
| Current year | 5.35 | 17 | $2.85B | -0.1% |
| Next year | 5.89 | 16 | $3.01B | +5.4% |
Analyst targets & ownership
Mean target$135.87
High target$165.00
Low target$110.00
Implied upside-11.37%
Analyst count15
ConsensusBUY
Strong buy / Buy0 / 6
Hold11
Sell / Strong sell0 / 1
Held by insiders0.26%
Held by institutions96.61%
Institutions holding769
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
151.18
+1.40% from price
SMA 20
143.62
+6.74% from price
SMA 50
129.66
+18.23% from price
SMA 100
117.15
+30.86% from price
SMA 200
106.84
+43.48% from price
EMA 12
149.43
+2.59% from price
EMA 26
142.04
+7.93% from price
EMA 50
132.94
+15.31% from price
RSI (14)
66.1
Neutral
MACD (12,26,9)
7.39
Hist 0.20
ATR (14)
5.82
3.80% of price
Realised vol 30D
41.9%
Annualised
Bollinger upper
164.79
20, 2σ
Bollinger lower
122.45
20, 2σ
50 / 200 cross
Golden
129.66 vs 106.84
Trend bias
Above 200
+43.48%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.16
More volatile than market
Correlation to SPY
0.39
Loosely linked
Realised vol 30D
41.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-30.1%
Peak to trough
Max drawdown 5Y
-59.2%
Peak to trough
ATR 14
5.82
3.80% of price
Beta (reported)
1.06
5Y monthly, from filing
Short interest
Shares short
6.22M
Prior 6.42M
Change vs prior
-3.1%
Shorts covering
% of float
8.35%
Normal
% of shares out
5.57%
Against total outstanding
Days to cover
3.6
Liquid
Float
102.49M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 6, 26 | William Blair | INITIATED | — | Outperform |
| Sep 4, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Sep 1, 26 | RBC Capital | INITIATED | — | Sector Perform |
| Aug 5, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Jul 6, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| May 7, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| May 6, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| May 6, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| May 6, 26 | Stifel | MAINTAINED | Hold | Hold |
| May 4, 26 | Baird | MAINTAINED | Outperform | Outperform |
| Apr 14, 26 | Goldman Sachs | MAINTAINED | Neutral | Neutral |
| Apr 14, 26 | Barclays | DOWNGRADE | Overweight | Equal-Weight |
Dividends & splits
Forward rate$0.28 / yr
Forward yield0.18%
5-year avg yield0.23%
Payout ratio13.40%
Ex-dividend dateOct 23, 2026
Next pay dateNov 13, 2026
Last split2:1
Split dateJun 4, 2001
SEC filings
Periodic Financial Reports
10-Q · 2026-08-11
Corporate Changes & Voting Matters
8-K · 2026-08-04
Annual report of employee stock purchase
11-K · 2026-06-23
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-06-01
Periodic Financial Reports
10-Q · 2026-05-12
Corporate Changes & Voting Matters
8-K · 2026-05-05
Corporate Changes & Voting Matters
8-K · 2026-05-01
Proxy Statements
DEF 14A · 2026-03-16
Headlines
Barclays Adjusts Price Target on Revvity to $160 From $115, Maintains Equalweight Rating
MT Newswires · 21h ago
Revvity to Host Investor Day
Business Wire · 21h ago
William Blair Initiates Revvity at Outperform
MT Newswires · 1d ago
Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · 5d ago
Revvity to Hold Earnings Call on November 3, 2026
Business Wire · 5d ago
Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · 8d ago
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Zacks · 8d ago
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
StockStory · 9d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.